• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Product Markets, The

$995.00 – $1,990.00

Clear
SKU: KLI2384194 Categories: Healthcare Information Technology, Healthcare Market Research Pages: 200
  • Description
  • Table of Contents
  • Latest reports

Description

At their most basic level, wellness programs represent an attempt to encourage good health and thereby decrease utilization of health care products and services. They have evolved out of necessity from the current U.S. health care system, in response to a variety of factors including continually rising costs of care and declining quality of life.

A Comprehensive Look at the ‘Wellness’ Industry

Utilization of wellness programs in the United States has experienced strong recent growth this is expected to continue through the forecast period. As more people participate in wellness programs, their usage of various health care products and services will be affected, as well the revenues of wellness program providers.

This report looks at the emerging wellness industry and estimates the market for wellness related products and services. This portion of the report examines:

  • Drivers of Wellness Services
  • Utilization Statistics
  • Major Companies and Offerings
  • Current Wellness Program Market Size
  • Innovative Approaches
  • Results of Programs
  • General Trends (Weak U.S. Economy, Postponing of Retirement, EMR, Rising Interest in Anti-Aging)
  • Industry Trends
  • (Internet-Based Wellness Programs, Usage of Financial Incentives, Emergence of Retail Clinics)
    A Report No Pharmaceutical, Device or Testing Product Marketer Should Be Without
    If wellness programs are effective, there should be an impact on all healthcare industries: pharmaceuticals, devices and diagnostics. Positive impact for some, negative for others. As part of Kalorama’s unique analysis on this topic, this report also takes a look at how the popularity of wellness programs will effect other markets. The report estimates the positive or negative sales impact of wellness programs upon established U.S. markets for various health care products and services including:

     

  • Allergy Medicines
  • Cholesterol Reducers
  • Diabetes Drugs
  • Gastrointestinal Medications/Proton Pump Inhibitors
  • Hypertension Medicines
  • Over-the-Counter (OTC) Medicines
  • Influenza Vaccines
  • Cervical Cancer Vaccines
  • Diagnostic Tests
  • Cardiovascular, Gastric Banding, and other Devices
  • Surgeries,
  • Imaging
  • Other Medical Services
    Within each of these market segments, products, services and/or sub-segments were selected that will particularly be affected by wellness programs. Products, services and/or sub-segments that are not expected to be significantly impacted were not included.Sales estimates for each market segment represent U.S. revenues and are expressed in current dollars. Estimates are provided for the historic 2004 – 2008 period and forecasts are provided through 2013. Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources. Interviews with company representatives and other experts were conducted to capture the perspectives from industry participants’ point of view and assess trends, and form the basis of the forecasting and competitive analysis.

    Because this industry is extremely fragmented, with thousands of providers offering many different types of programs tailored to different patient populations, an effort was made to include a broad representation of groups. Companies profiled include:

  • Aetna
  • Azente Wellness
  • Cigna
  • Coleman Wellness Solutions
  • ConnectiCare
  • Corporate Wellness
  • ConvergenceHealth
  • CuraLinc Healthcare
  • Dynamic Wellness
  • Employee Health Management Systems
  • Hawaii Medical Assurance Association
  • incentaHEALTH
  • KC Wellness
  • Kersh Risk Management.
  • Kronos Optimal Health Company
  • Mayo Clinic Health Solutions
  • MedHealth Solutions
  • MO Healthnet
  • Multicare Health System
  • National Corporate Wellness.
  • Nuvita
  • PATH
  • Physicians Medical Group of Santa Cruz County
  • Preventure
  • Professional Health Services
  • Pure Wellness
  • Summit Health..
  • San Francisco Wellness Initiative
  • US Corporate Wellness
  • Wellness Advantage
  • Wellness Corporate Solutions
  • Wellness Works
  • Wyoming State Wellness Program

Table of Contents

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Wellness Programs And Their Impact on U.S. Healthcare Markets
  • Scope and Methodology
  • Introduction
    • The U.S. Health Care System
    • High Cost of Care
    • Wellness Programs
    • Wellness Program Economics
  • Key Healthcare Markets Impacted by Wellness Programs
    • Total Effects
    • Prescription Medicines
    • OTC Medicines
    • Adult Vaccines
    • Clinical Diagnostic Tests
    • Medical Devices
    • Medical Services
  • Wellness Programs market
    • Market Size
    • Issues and Trends

CHAPTER TWO: INTRODUCTION

  • The U.S. Health Care System Today
    • Health Care Populations
    • Public Health Care
    • Private Health Care
    • The Uninsured and Underinsured
    • The High Cost of Care
    • Out of Pocket Health care Expenditures
    • Quality Costs
    • Health Care Reform
      • Universal Federal Health Care Coverage
      • State Health Care Coverage
  • Costs Related To A Lack Of Wellness
    • Direct Cost Savings from Illness Prevention
    • Indirect Cost Savings from Improved Productivity
  • Wellness Programs
    • Program Goals
    • Target Populations
    • Expectant Mothers
      • Senior Citizens
      • The Obese
      • Persons with Chronic Conditions
      • Arthritis
      • Cardiovascular Disease
      • Diabetes
      • Lung Disease
      • Osteoporosis
    • Types of Programs
      • Program Sponsors
      • Program Administrators
      • Components of Wellness Programs
      • Wellness Program Best Practices
    • Program Economics
    • Costs of Running a Wellness Program
    • Savings in Health care Expenses
    • Current Utilization
      • Drivers and Restraints
      • Program Sponsors
      • Program Participants

CHAPTER THREE: KEY HEALTH CARE MARKETS IMPACTED BY WELLNESS PROGRAMS

  • Prescription Medicines
    • Allergy Medicines
    • Effects of Wellness Programs on Utilization
    • Allergy Drug Revenues Lost to Wellness Programs, 2004-2013
    • Cholesterol Reducers
    • Effects of Wellness Programs on Utilization
    • Cholesterol Reducer Revenues Lost to Wellness Programs, 2004-2013
    • Diabetes Drugs
    • Effects of Wellness Programs on Utilization
    • Diabetes Drug Revenues Lost to Wellness Programs, 2004-2013
    • Gastrointestinal Medications/Proton Pump Inhibitors
    • Effects of Wellness Programs on Utilization
    • Gastrointestinal Drug/PPI Revenues Lost to Wellness Programs, 2004-2013
    • Hypertension Medicines
    • Effects of Wellness Programs on Utilization
    • Hypertension Drug Revenues Lost to Wellness Programs, 2004-2013
    • Other Prescription Medicines
    • Total Effect on Prescription Medicines
  • Non-Prescription Medicines
    • Allergy Medicines
    • Effects of Wellness Programs on Utilization
    • OTC Allergy Remedy Revenues Gained From Wellness Programs, 2004-2013
    • Blood Glucose Testing Products
    • Effects of Wellness Programs on Utilization
    • OTC Blood Glucose Testing Revenues Gained From Wellness Programs, 2004-2013
    • Gastrointestinal Medications
    • Effects of Wellness Programs on Utilization
    • OTC Gastrointestinal Drug Revenues Gained From Wellness Programs, 2004-2013
    • Smoking Cessation Products
    • Effects of Wellness Programs on Utilization
    • OTC Smoking Cessation Product Revenues From Wellness Programs, 2004-2013
    • Weight Loss Products
    • Effects of Wellness Programs on Utilization
    • OTC Weight Loss Drug Revenues Gained From Wellness Programs, 2004-2013
    • Other Non-Prescription Medicines
    • Total Effect on Non-Prescription Medicines
  • Adult Vaccines
    • Influenza
    • Effects of Wellness Programs on Utilization
    • Influenza Vaccine Revenues Gained From Wellness Programs, 2004-2013
    • Cervical Cancer
    • Effects of Wellness Programs on Utilization
    • Cervical Cancer Vaccine Revenues Gained From Wellness Programs, 2004-2013
    • Other Vaccines
    • Total Effect on Vaccines
  • Clinical Diagnostic Tests
    • Point of Care Tests
    • Effects of Wellness Programs on Utilization
    • POC Test Sales Gained from Wellness Programs, 2004-2013
    • Clinical Chemistry and Immunoassay Tests
    • Effects of Wellness Programs on Utilization
    • Clinical Chemistry and Immunoassay Test Sales Gained from Wellness Programs, 2004-2013
    • Other Types of Clinical Diagnostic Tests
    • Total Effect on Clinical Diagnostic Tests
  • Medical Devices
    • Cardiovascular Devices
    • Effects of Wellness Programs on Utilization
    • Cardiovascular Device Revenues Lost to Wellness Programs, 2004-2013
    • Gastric Banding Devices
    • Effects of Wellness Programs on Utilization
    • Gastric Banding Device Revenues Lost to Wellness Programs, 2004-2013
    • Other Medical Devices
    • Total Effect on Medical Devices
  • Medical Services
    • Surgical Interventions
    • Effects of Wellness Programs on Utilization
    • Surgical Intervention Revenues Lost to Wellness Programs, 2004-2013
    • Diagnostic Imaging
    • Effects of Wellness Programs on Utilization
    • Medical Imaging Revenues Lost to Wellness Programs, 2004-2013
    • Other Medical Services
    • Total Effect on Medical Services
  • Total Effects of Wellness Programs
    • Total Health Care Industry
    • Impact of Wellness Programs
    • Segment Contribution
    • Trends Over Time

CHAPTER FOUR: WELLNESS PROGRAMS MARKET

  • Program Provider Revenues
  • Issues and Trends
  • Weak U.S. Economy
  • Postponing of Retirement
  • Internet-Based Wellness Programs
  • Usage of Financial Incentives
  • Electronic Medical Records
  • Declining Public Health
  • Pressure to Democratize Wellness
  • Rising Interest in Anti-Aging
  • Emergence of Retail Clinics

CHAPTER FIVE: PROVIDER PROFILES

  • Aetna
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • Azente Wellness
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • Cigna
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • Coleman Wellness Solutions
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • ConnectiCare
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • Corporate Wellness
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • ConvergenceHealth
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • CuraLinc Healthcare
    • History and Lines of Business
  • Dynamic Wellness
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • Employee Health Management Systems
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • Hawaii Medical Assurance Association
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • incentaHEALTH
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • Infinite Wellness Solutions
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • KC Wellness
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • Kersh Risk Management
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • Kronos Optimal Health Company
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • Mayo Clinic Health Solutions
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • MedHealth Solutions
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • MO Healthnet
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • Multicare Health System
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • National Corporate Wellness
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • Nuvita
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • PATH
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • Physicians Medical Group of Santa Cruz County
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • Preventure
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • Professional Health Services
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • Pure Wellness
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • San Francisco Wellness Initiative
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • Summit Health
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • US Corporate Wellness
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • Wellness Advantage
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • Wellness Corporate Solutions
    • History and Lines of Business
    • Financial Information
    • Wellness Programs
  • Wellness Works
    • History and Lines of Business
    • Financial Information
  • Wyoming State Wellness Program
    • History and Lines of Business
    • Financial Information
    • Wellness Programs

TABLE OF EXHIBITS

CHAPTER TWO: INTRODUCTION

  • Figure 2-1: National Health Expenditures (NHE) and NHE as a Percent of GDP, 1980-2017
  • Figure 2-2: Premium Increases vs. Increases in Workers Earnings and Prices, 1989-2008
  • Figure 2-3: Consumer Out of Pocket Expenditures per Worker, 2003-2013
  • Figure 2-3: Unnecessary Deaths Resulting From Variations in Health Care Quality, 2008
  • Table 2-1: U.S. Health Care Coverage by State, 2009
  • Figure 2-4: U.S. Costs for Illness Treatment and Prevention, 1980-2017
  • Table 2-2: Obesity in the United States, 1980-2013
  • Table 2-3: Common Diseases of the Lungs, 2009

CHAPTER ONE: KEY HEALTH CARE MARKETS IMPACTED BY WELLNESS PROGRAMS

  • Table 3-1: Effect of Wellness Programs on Key U.S. Health care Markets
  • Table 3-2: U.S. Rx Allergy Drug Sales and Impact of Wellness Programs, 2004 -2013
  • Table 3-3: Types of Cholesterol Reducing Medications and Their Effect
  • Table 3-4: U.S. Rx Cholesterol Drug Sales and Impact of Wellness Programs, 2004-2013
  • Table 3-5: U.S. Diabetes Drug Sales and Impact of Wellness Programs, 2004-2013
  • Table 3-6: U.S. Rx Gastrointestinal/PPI Drug Sales and Impact of Wellness Programs, 2004-2013
  • Table 3-7: U.S. Rx Hypertension Drug Sales and Impact of Wellness Programs, 2004-2013
  • Table 3-8: Total U.S. Rx Drug Sales and Impact of Wellness Programs on Selected Drug Groups, 2004-2013
  • Figure 3-1: Impact of Wellness Programs on Selected Rx Drug Groups, 2004-2013
  • Table 3-9: U.S. OTC Allergy Remedy Sales and Impact of Wellness Programs, 2004-2013
  • Table 3-10: U.S. Blood Glucose Testing Sales and Impact of Wellness Programs, 2004-2013
  • Table 3-11: U.S. OTC Gastrointestinal Drug Sales and Impact of Wellness Programs, 2004-2013
  • Table 3-12: U.S. OTC Smoking Cessation Drug Sales and Impact of Wellness Programs, 2004-2013
  • Table 3-13: U.S. OTC Weight Loss Drug Sales and Impact of Wellness Programs, 2004-2013
  • Table 3-14: Total U.S. OTC Drug Sales and Impact of Wellness Programs on Selected Drug Groups, 2004-2013
  • Figure 3-2: Impact of Wellness Programs on Selected OTC Drug Groups, 2004-2013
  • Table 3-15: U.S. Influenza Vaccine Sales and Impact of Wellness Progress 2004-2013
  • Table 3-16: U.S. Cervical Cancer Vaccine Sales and Impact of Wellness Programs, 2004-2013
  • Table 3-17: U.S. Vaccine Sales and Impact of Wellness Programs, 2004-2013
  • Figure 3-3: Impact of Wellness Programs on Vaccine Sales, 2004-2013
  • Table 3-18: U.S. POC Test Sales and Impact of Wellness Programs, 2004-2013
  • Table 3-19: U.S. Clinical Chemistry and Immunoassay Test Sales and Impact of Wellness Programs, 2004-2013
  • Table 3-20: U.S. Clinical Test Sales and Impact of Wellness Programs, 2004-2013
  • Figure 3-4: Impact of Wellness Programs on Clinical Diagnostic Tests, 2004-2013
  • Table 3-21: U.S. Cardiovascular Device Sales and Impact of Wellness Programs on Selected Drug Groups, 2004-2013
  • Table 3-22: U.S. Gastric Banding Device Sales and Impact of Wellness Programs, 2004-2013
  • Table 3-23: Selected U.S. Medical Device Sales and Impact of Wellness Programs, 2004-2013
  • Figure 3-5: Impact of Wellness Programs on Medical Devices, 2004-2013
  • Table 3-24: U.S. Surgical Intervention Revenues and Impact of Wellness Programs, 2004-2013
  • Table 3-25: U.S. Medical Imaging Revenues and Impact of Wellness Programs, 2004-2013
  • Table 3-26: Selected U.S. Medical Service Revenues and Impact of Wellness Programs, 2004-2013
  • Figure 3-6: Impact of Wellness Programs on Medical Services, 2004-2013
  • Table 3-27: Total U.S. Health Care Market Revenues, 2004-2013,
  • Figure 3-7: Total U.S. Health Care Market, by Segment, 2008
  • Figure 3-8: Total U.S. Health Care Market, by Segment, 2013
  • Table 3-28: U.S. Health Care Revenues Lost or Gained from Wellness Programs, 2004-2013
  • Figure 3-9: U.S. Health Care Revenues Lost or Gained from Wellness Programs, by Segment, 2004-2013
  • Figure 3-10: Total Effect on U.S. Health Care Revenues Lost or Gained from Wellness Programs, by Segment, 2004 – 2013
  • Table 3-29: Growth of Total U.S. Health Care Revenues and Revenues Lost or Gained from Wellness Programs, 2004-2013
  • Figure 3-11: Annual U.S. Health Care Industry Growth vs. Growth of Lost or Gained Revenues from Wellness Programs, by Segment, 2004-2008
  • Figure 3-12: Annual U.S. Health Care Industry Growth vs. Growth of Lost or Gained Revenues from Wellness Programs, by Segment, 2008-2013

CHAPTER FOUR: WELLNESS PROGRAMS MARKET

  • Table 4-1: U.S. Wellness Programs Market, 2004-2013
  • Figure 4-1: U.S. Spending on Wellness Programs as a Proportion of Total Spending on Health Care Prevention, 2004-2013
  • Table 4-2: Effect on Wellness Programs of Industry Trends

CHAPTER FIVE: PROVIDER PROFILES

  • Table 5-1: Aetna’s Revnue and Net Earnings, 2006-2008
  • Table 5-2: Cigna’s Revnue and Net Earnings, 2006-2008

 

    World Market for Laboratory Information Systems (LIS): Software, Hardware, and Implementation for Clinical Labs, 2022-2027
    October 18, 2023
    Blockchain Technologies in Healthcare
    November 22, 2019
    The Market for Artificial Intelligence (AI) in Healthcare
    September 27, 2019
    Internet of Things (IoT) in Healthcare
    September 19, 2019

Related products

  • Placeholder image

    Organ Transplant Immunosuppressive Markets

    $995.00 – $1,990.00
  • Placeholder image

    Healthcare in a Recession (OTC, Generics, Out of Pocket Spending, Healthcare Legislation, Retail Clinics, Outsourcing and Other Topics)

    $500.00 – $3,990.00
  • Placeholder image

    Long Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living

    $3,995.00 – $7,990.00
  • Placeholder image

    World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers)

    $995.00 – $7,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Sy...Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads
Scroll to top